DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Straumann A, Conus S, Grzonka P. et al
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial.
Gut 2010; 59: 21-30
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.